ERBB2 and breast carcinoma: PGC1α is important for glutamine metabolism in ERBB2‐positive breast cancer (McGuirk et al., 2013) and glutamine transporters are proposed therapeutic targets in melanoma (Wang et al., 2014), highlighting the therapeutic potential of this metabolic pathway.